Myotonic Dystrophy
|
0.010 |
Biomarker
|
disease |
BEFREE |
Altered phosphorylation and intracellular distribution of a (CUG)n triplet repeat RNA-binding protein in patients with myotonic dystrophy and in myotonin protein kinase knockout mice.
|
9371827 |
1997 |
Influenza
|
0.010 |
Biomarker
|
disease |
BEFREE |
Using the 5' UTR of the influenza virus nucleocapsid protein (NP) mRNA as bait, we identified the cellular RNA-recognition motif containing RNA-binding protein G-rich sequence factor 1 (GRSF-1) as a positive-acting translational regulatory factor.
|
10359774 |
1999 |
Malignant neoplasm of liver
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
Aberrant expression of fetal RNA-binding protein p62 in liver cancer and liver cirrhosis.
|
11549587 |
2001 |
Liver Cirrhosis
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Aberrant expression of fetal RNA-binding protein p62 in liver cancer and liver cirrhosis.
|
11549587 |
2001 |
Adult Liver Carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Aberrant expression of fetal RNA-binding protein p62 in liver cancer and liver cirrhosis.
|
11549587 |
2001 |
Liver and Intrahepatic Biliary Tract Carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Aberrant expression of fetal RNA-binding protein p62 in liver cancer and liver cirrhosis.
|
11549587 |
2001 |
Liver carcinoma
|
0.030 |
Biomarker
|
disease |
BEFREE |
Expression of the Musashi1 gene encoding the RNA-binding protein in human hepatoma cell lines.
|
12054577 |
2002 |
Liver neoplasms
|
0.010 |
Biomarker
|
group |
BEFREE |
Expression of the Musashi1 gene encoding the RNA-binding protein in human hepatoma cell lines.
|
12054577 |
2002 |
Fragile X Syndrome
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
Loss of the RNA-binding protein FMRP (fragile X mental retardation protein) leads to fragile X syndrome, the most common form of inherited mental retardation.
|
12594214 |
2003 |
Carcinoma of lung
|
0.150 |
GeneticVariation
|
disease |
BEFREE |
L523S, an RNA-binding protein as a potential therapeutic target for lung cancer.
|
12644826 |
2003 |
Malignant neoplasm of lung
|
0.050 |
GeneticVariation
|
disease |
BEFREE |
L523S, an RNA-binding protein as a potential therapeutic target for lung cancer.
|
12644826 |
2003 |
Primary malignant neoplasm of lung
|
0.050 |
GeneticVariation
|
disease |
BEFREE |
L523S, an RNA-binding protein as a potential therapeutic target for lung cancer.
|
12644826 |
2003 |
Malignant Squamous Cell Neoplasm
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
By using a combination of cDNA subtraction and microarray analysis, we previously reported the identification of an RNA-binding protein within the KOC family, L523S, to be overexpressed in squamous cell cancers of the lung.
|
12644826 |
2003 |
Malignant Neoplasms
|
0.100 |
GeneticVariation
|
group |
BEFREE |
Immunohistochemical analysis of paired tumor and normal tissue specimens revealed that the expression and cytoplasmic abundance of the RNA-binding protein HuR increased with malignancy, particularly in colon carcinomas.
|
14562043 |
2003 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Immunohistochemical analysis of paired tumor and normal tissue specimens revealed that the expression and cytoplasmic abundance of the RNA-binding protein HuR increased with malignancy, particularly in colon carcinomas.
|
14562043 |
2003 |
Carcinogenesis
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
Role of the RNA-binding protein HuR in colon carcinogenesis.
|
14562043 |
2003 |
Primary malignant neoplasm
|
0.100 |
GeneticVariation
|
group |
BEFREE |
Immunohistochemical analysis of paired tumor and normal tissue specimens revealed that the expression and cytoplasmic abundance of the RNA-binding protein HuR increased with malignancy, particularly in colon carcinomas.
|
14562043 |
2003 |
Carcinoma
|
0.010 |
GeneticVariation
|
group |
BEFREE |
Immunohistochemical analysis of paired tumor and normal tissue specimens revealed that the expression and cytoplasmic abundance of the RNA-binding protein HuR increased with malignancy, particularly in colon carcinomas.
|
14562043 |
2003 |
Prostate carcinoma
|
0.050 |
Biomarker
|
disease |
BEFREE |
Up-regulated expression of mammary tumor 8 kDa protein (MAT-8), complement component C1S (C1S), ferritin heavy chain (FTH1), peptidyl-prolyl cis-trans isomerase A (PPIA), RNA-binding protein regulatory subunit DJ-1 protein (DJ-1) and vacuolar ATP synthase subunit F (ATP6V1F) was determined in prostate carcinoma and confirmed by using quantitative real-time RT-PCR analyses.
|
14654946 |
2004 |
Lung Neoplasms
|
0.010 |
AlteredExpression
|
group |
BEFREE |
Expression of the RNA-binding protein CRD-BP in brain and non-small cell lung tumors.
|
15159028 |
2004 |
Malignant neoplasm of liver
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
RBMY, a male germ cell-specific RNA-binding protein, activated in human liver cancers and transforms rodent fibroblasts.
|
15184870 |
2004 |
Carcinoma of lung
|
0.150 |
Biomarker
|
disease |
BEFREE |
alpha CP-4 is an RNA-binding protein coded by PCBP4, a gene mapped to 3p21, a common deleted region in lung cancer.
|
15205328 |
2004 |
Malignant neoplasm of lung
|
0.050 |
Biomarker
|
disease |
BEFREE |
alpha CP-4 is an RNA-binding protein coded by PCBP4, a gene mapped to 3p21, a common deleted region in lung cancer.
|
15205328 |
2004 |
Primary malignant neoplasm of lung
|
0.050 |
Biomarker
|
disease |
BEFREE |
alpha CP-4 is an RNA-binding protein coded by PCBP4, a gene mapped to 3p21, a common deleted region in lung cancer.
|
15205328 |
2004 |
Parkinson Disease
|
0.010 |
Biomarker
|
disease |
BEFREE |
Association between the neuron-specific RNA-binding protein ELAVL4 and Parkinson disease.
|
15827745 |
2005 |